GSK3439171 / GSK - LARVOL DELTA

First Time in Human (FTIH) Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of Single and Repeat Doses of GSK3439171A in Healthy Subjects and to Assess Food Effect (clinicaltrials.gov) - P1; N=66; Completed; Sponsor: GlaxoSmithKline; Recruiting ➔ Completed

Clinical • Trial completion